$HIPH -Its aerosol sanitizer product prototype just

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
204
$HIPH -Its aerosol sanitizer product prototype just launched yesterday. News/Pr on Globenewswire below

American Premium Water Corp. (OTC:HIPH) Announces Development of Prototype Aerosol Sanitizer Machine Using Proprietary Hydro-Nano Water

GlobeNewswireApril 22, 2020
The Device is Currently in the Developmental Stage Pending Significant Testing Prior to Certification for Commercial Use
PLAYA VISTA, CA, April 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – American Premium Water Corporation (HIPH) announces that it has developed a prototype device that aerosolizes a mixture of the Company’s proprietary Hydro-Nano water and disinfectant agents. This prototype device is currently in the developmental phase; extensive research, environmental, and laboratory testing will be required to be completed before the device and Hydro-Nano water mixture can be commercialized. The Company previously published results in April 2019 on the efficacy of its Hydro Nano technology. The report showed that the synthesis in the Company’s Hydro Nano water reduces the size of the majority of the CBD molecules encapsulated to one nanometer or less in diameter. A full copy of the report can be found here.
The Hydro-Nano water used in the prototype does not contain CBD or any hemp material. The prototype device, which aerosolizes a mixture of Hydro Nano water with disinfecting agents. The Company hypothesizes that the Hydro Nano water will have the same effect on the added sterilizing agents as it does with CBD, shrinking the size of the particles to less than one nanometer in size, which will lead to a more effective sterilizing solution by creating a cloud that will disinfect contact surfaces, and potentially the atmosphere in a room or building. To date, there has not been any testing done by the Company to support or make any claims of sterilization or disinfectant potency about this device or the contents contained in it. A video of the prototype device and its process can be found here.
American Premium CEO Ryan Fishoff commented, “I am pleased to announce the completion of a prototype device that aerosolizes our Hydro Nano water mixed with disinfectants. This is the first step in a long process to develop a usable and scalable product for commercial distribution. Current world events have placed a much greater emphasis on sanitation and sterilization, and the Company believes this device could potentially fulfill that need. The development of this prototype is the first of many steps towards a viable commercial device and formulation; significant laboratory and environmental testing has to be conducted before this device can be sold. But the potential is great; there are many commercial customers that could utilize this technology such as hotels, malls, movie theaters, department stores, boutiques, hospitals, and other retail businesses that would benefit from a quick and effective sanitation solution. I have always felt that the Company’s nanotechnology is a tremendous asset that gets overlooked; there are many potential applications of this technology beyond CBD and hemp. The Company will continue to explore ways to leverage our proprietary nanotech to create shareholder value. I look forward to updating shareholders on our progress in testing, achieving other milestones in the development process of this device, and other avenues that the Company is exploring to monetize existing nanotechnology,” concluded Mr. Fishoff
Vanexxe 2oz can be purchased on Amazon here.
Goldman Research initiated coverage of the Company on February 13th, 2020, giving a $0.0125 price target. To read the full report, click here
About American Premium Water Corp.
American Premium Water (HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of Nano technologies paired without cannabidiol (CBD) to treat health disorders and enhance quality of life. The company’s portfolio includes the LALPINA Hydro and LALPINA CBD brands (www.lalpinahydrocbd.com), Gents (www.gentsco.com), Vanexxe (www.vanexxe.com) plant + body essentials (www.plantbodyessentials.com).
Safe Harbor Notice
Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC" EDGAR database.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fed Holds Steady, But CD Rates Climb: Savers' Edge

Updated Category News Views 121

The Fed Sits Tight, But CD Rates Surge Isn't it a kicker when the Fed holds rates steady, yet the CD market is buzzing like a crowded trading floor on a bull run? We've seen the Federal Reserve hold its ground without budging interest rates, keeping everyone guessing while inflation's still a shadow in the corner. But the star of the show here isn't the Fed's poker...

Continue Reading
CaringKind Merger Expands Alzheimer's Care in NY

Updated Category News Views 19

A New Chapter for Dementia Care: The CaringKind Merger Cornerstone local relationships plus a fresh westerly breeze of national presence—that's the gist of the recent union between CaringKind and Alzheimer's Disease Resource Center. This isn't just a big deal for families in Nassau and Suffolk counties, it's a seismic shift for dementia care reaching across state...

Continue Reading
Cat Financial Shows Solid Q3 Growth Amid Challenges

Updated Category News Views 82

Healthy Gains in Revenues and Profits Well, Cat Financial's latest report is another piece of the puzzle showing steady, if not spectacular, growth. They've jacked up their revenues by 10% for the third quarter of 2026 compared to last year's same stretch. This puts the revenues at $1.02 billion, a $95 million bump from the previous year. Pretty impressive. The profit saw...

Continue Reading
CallRail's New Insight Tool: Navigating the Competitive Landscape

Updated Category News Views 11

How CallRail's New Feature Changes the Game Ever sit in a boardroom meeting and wonder what your lead numbers really mean? CallRail just dropped a new feature that could change that. This AI-powered platform is now decking its 225,000 businesses with market insights to not just know their numbers but to understand how they stack up against their competition in the same...

Continue Reading
Celebrate Dr. David Neff's Healthcare Legacy

Updated Category News Views 77

An Icon in Medicine and Innovation Dr. David R. Neff's recognition as a Pinnacle Lifetime Member marks a storied journey through medicine and healthcare innovation. Decades of Dedication to Patient Care For over 45 years, Neff carved out a niche in medicine that few can parallel. His overarching focus on infectious disease, cancer, and more represents a holistic approach...

Continue Reading
Busch Gardens' Holiday Extravaganza Lights Up 2026

Updated Category News Views 8

A Dazzling Holiday Transformation Awaits Forget the mundane holiday light displays. Busch Gardens is cranking it up a notch with their annual Christmas Town spectacle, kicking off on November 13. With two parks—Tampa Bay and Williamsburg—each delivering a unique experience, prepare for an immersive dive into holiday cheer that's packed with glitz, entertainment, and,...

Continue Reading
AST SpaceMobile Suit Seeks Lead Plaintiff by November 13

Updated Category News Views 86

The Legal Rigmarole The market's got its knickers in a twist over AST SpaceMobile, folks. If you've been dabbling in NASDAQ:ASTS between March '25 and mid-July '26, it's time to perk up those ears. The legal eagles at Robbins Geller Rudman & Dowd LLP are rallying the troops for a class action lawsuit with you front and center. Deadline's looming on November 13, 2026, for...

Continue Reading
Bulletproof Gets Nod for AI Expertise, Eyes Future Growth

Updated Category News Views 0

Bulletproof's Recognition: A Sign of AI Prowess Let's dive right into today's news: Bulletproof just snagged a spot on the 2026 CRN AI Innovators list. Now, this is big leagues stuff, especially since this list highlights the top dogs in the AI space across North America. We're talking about managed service providers, value-added resellers, and all those tech wizards who...

Continue Reading
Unpacking NOMMA's Unique Blend of Education Strategies

Updated Category News Views 41

Introducing NOMMA's Unique Approach Well, here’s one for the books—an educational model that smacks of good ol’ discipline and sharpens minds for what's beyond the classroom. Located in New Orleans, the Military and Maritime Academy, or NOMMA if you want to keep things snappy, serves up an education with a difference. Not only does it prepare cadets academically,...

Continue Reading
Xyte's Record Quarter: Surging Demand & New CEO

Updated Category News Views 62

Setting New Records in the AV Industry There's buzz in the air over in Hoboken, New Jersey. Xyte, the AI cloud maestro you're starting to hear about more and more, has just smashed its own records this past September. It's not just a flash in the pan, either—this isn't the first time they've knocked it out of the park. Thanks to burgeoning enterprise demand and a...

Continue Reading

Top 5 Most Recently Viewed Articles

Deckers Outdoor Adjusts to Split with New Price Target Set

Updated Category News Views 50

Deckers Outdoor Stock Price Target Update Recently, Evercore ISI made headlines by revising its price target for the shares of Deckers Outdoor (NYSE: DECK), adjusting it down to $183 from the previous level of $1,100. This reduction, while significant, comes after the company undertook a 6-for-1 stock split, a move aimed at making the stock more appealing to investors....

Continue Reading
Celebrating Exceptional Women in Financial Advisory Services

Updated Category News Views 278

Recognizing Talented Women in Financial Advisory It is with great pleasure that Spectrum Investment Advisors announces significant achievements within its team. Suzanne (Sue) Weeden and Emily Zimmerman have both been honored on the prestigious National Association of Plan Advisors (NAPA) Top Women Advisors List for the year 2025. This recognition emphasizes not just the...

Continue Reading
Analysts Adjust Projections for GE Aerospace's Q2 Earnings

Updated Category News Views 95

Analysts Upgrade Expectations for GE Aerospace’s Earnings GE Aerospace is on the verge of reporting its second quarter earnings, and there is much to anticipate. Analysts are observing closely, with expectations set high for the company, specifically regarding its profitability and revenue generation. This esteemed aerospace segment is amidst a significant growth phase,...

Continue Reading
Innovative Health Care Initiative Launched for Students

Updated Category News Views 292

New Health Care Program for Students The Inland Empire Health Plan (IEHP), along with the California Community College system and the San Bernardino Community College District (SBCCD), has introduced a transformative health care access program aimed specifically at college students. This innovative initiative, titled the Inland Empire Health Plan Equitable Support...

Continue Reading
Rallybio’s Breakthroughs in HPP Treatment and Clinical Advancements

Updated Category News Views 115

Rallybio Corp. (NASDAQ:RLYB) grabbed attention back in 2024 with its hypophosphatasia (HPP) treatment data, leaving desks buzzing about potential outcomes. Analysts at H.C. Wainwright reiterated a Buy rating, slapping a $6.00 price target on the stock based on the company’s compelling data from non-clinical studies showing ENPP1 inhibition's prospects for tackling this...

Continue Reading